- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07229105
Comparative Effectiveness of Remineralization Agents on Attachment-Associated Demineralization in Clear Aligner Patients
Comparative Effectiveness of Remineralization Agents on Attachment-Associated Demineralization in Clear Aligner Patients: A 6-Month DIAGNOdent-Based Observational Study
Background/ Objectives: Clear aligner attachments increase the risk of white spot lesions (WSL), with a 35.5% incidence in adolescents. The number of anterior attachments is an independent risk factor (OR=2.192). Despite 17 million patients treated worldwide, no study has quantitatively assessed demineralization around attachment margins. To compare the effectiveness of CPP-ACP, nano-hydroxyapatite (nHAp), and fluoride varnish versus a control for attachment-associated demineralization using DIAGNOdent monitoring.
Methods: This prospective observational study evaluated 52 patients; 45 were enrolled, and 40 completed after five pre-baseline withdrawals. Participants were allocated to four groups (n=10 each): Group A (control, fluoride toothpaste), Group B (CPP-ACP daily), Group C (nHAp professional + home gel), and Group D (fluoride varnish quarterly). DIAGNOdent measurements were taken around attachments at baseline, 1, 3, and 6 months. Linear mixed-effects models analyzed group differences (p<0.05).
Study Overview
Status
Intervention / Treatment
Detailed Description
DIAGNOdent Measurement Protocol Calibration and Standardization The DIAGNOdent pen (KaVo, Biberach, Germany) was calibrated before each measurement session according to the manufacturer's instructions using a ceramic standard[18]. A single calibrated examiner performed all measurements to ensure consistency. Intra-examiner reliability was assessed using intraclass correlation coefficient (ICC) with two-way mixed model, absolute agreement, calculated from 30 repeated measurements at 10 randomly selected attachment sites (ICC = 0.85, 95% CI: 0.79-0.91).
Measurement Technique A standardized measurement protocol was employed for all DIAGNOdent assessments. Teeth were air-dried for 5 seconds prior to measurement, and the probe tip was positioned perpendicular to the enamel surface to ensure consistent readings. Four measurements were obtained per attachment site at the mesial, distal, gingival, and occlusal margins. Three measurement passes were performed at each site, with the maximum value recorded to represent the most advanced demineralization present. Measurements were conducted at four timepoints: baseline (T0), 1 month (T1), 3 months (T2), and 6 months (T3).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey (Türkiye)
- Bezmialem Vakif University, Faculty of Dentistry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 16-45 years
- Active clear aligner treatment with minimum 6 months remaining
- Presence of ≥10 attachments on anterior teeth and premolars
- Good general health
- Commitment to prescribed aligner wear (20-22 hours/day)
Exclusion Criteria:
- Active carious lesions
- Periodontal disease
- Fluorosis or enamel hypoplasia
- Current fluoride supplement use beyond standard toothpaste
- Pregnancy or lactation
- Systemic conditions affecting salivary flow
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Group A: Control
The participants used standard fluoride toothpaste (1450 ppm) twice daily, with no additional remineralization protocol.
|
|
|
Experimental: Group B: Casein Phosphopeptide-Amorphous Calcium Phosphate
In addition to standard fluoride toothpaste, participants applied GC Tooth Mousse (CPP-ACP) to their clear aligners once daily for 15 minutes before bedtime.
|
Participants applied a pea-sized amount of GC Tooth Mousse into each aligner once daily before bedtime.
They wore the aligners with the mousse for 15 minutes and were instructed not to rinse for 30 minutes post-application.
Other Names:
|
|
Experimental: Group C: Nano-Hydroxyapatite
Professional in-office application of 5% nHAp gel at baseline, 1, and 3 months, combined with daily home application of 1% nHAp gel into aligners.
|
A combined protocol involving: 1) Professional in-office application of 5% nHAp gel (BioWhiten ProOffice) at baseline, 1 month, and 3 months; and 2) Daily home application of 1% nHAp gel (Biowhiten Nanocare) into aligners every night before sleep.
Other Names:
|
|
Experimental: Group D: Professional Fluoride Varnish
Professional application of 5% sodium fluoride varnish (ProShield) applied to attachment margins at baseline and 3 months.
|
Professional application of 5% sodium fluoride varnish (ProShield) to all tooth surfaces, with special attention to attachment margins, at baseline and 3 months.
The varnish was left for 1 minute contact time before removal, with instructions not to eat/drink for 2 hours.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Enamel Demineralization (DIAGNOdent values).
Time Frame: Baseline (T0) to 6 months (T3).
|
Measurements taken using DIAGNOdent pen around attachment margins.
Validated cut-off values: 0-12 sound, 13-24 initial, >25 advanced.
|
Baseline (T0) to 6 months (T3).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Temporal Changes in Enamel Mineralization
Time Frame: 1 month (T1) and 3 months (T2)
|
Evaluation of DIAGNOdent values at intermediate time points to assess the progression or regression patterns (e.g., continuous improvement vs. biphasic response) of demineralization.
|
1 month (T1) and 3 months (T2)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09/15
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Caries
-
National University of San Marcos, PeruNot yet recruitingPit and Fissure Caries | Caries,Dental | Sealant DentalPeru
-
Ain Shams UniversityCompletedPulpitis | Caries | Caries,Dental | Reversible Pulpitis | Caries Class I | Caries; DentinEgypt
-
University of MinnesotaCompletedUsing Motivational Interviewing To Reduce Parental Risk-Related Behaviors For Early Childhood CariesCaries | Caries,DentalUnited States
-
Future University in EgyptNot yet recruitingDeep Caries | Caries, Dental
-
Federal University of PelotasRecruiting
-
Kompetansesenteret Tannhelse Midt (TkMidt)Karolinska Institutet; University of Bergen; Norwegian University of Science... and other collaboratorsActive, not recruiting
-
Marmara UniversityCompleted
-
Suez Canal UniversityCompleted
-
Pomeranian Medical University SzczecinCompleted
-
Universidad Autonoma de Baja CaliforniaNot yet recruitingDental Caries in Children | Caries, Dental | Caries; DentinMexico
Clinical Trials on GC Tooth Mousse
-
University Hospital, GhentGC EuropeCompleted
-
Cairo UniversityUnknownWhite Spot Lesion of ToothEgypt
-
Ruba Alaa El Din Adel El DamarisyUnknownWhite Spot Lesion of Tooth
-
University Hospital, GhentGC EuropeCompleted
-
University of ZurichBorrow FoundationCompletedErosion ProtectionSwitzerland
-
University of DundeeNHS TaysideCompletedOrthodontic Treatment | Demineralisation | White Spot LesionsUnited Kingdom
-
New York State Psychiatric InstituteSuspended
-
Research Foundation for Mental Hygiene, Inc.WithdrawnPosttraumatic Stress Disorder
-
Pharmiva ABCPS Research; Scandinavian Development Services AB; Key2Compliance ABActive, not recruitingBacterial Vaginosis | Vaginal | MicrobiologySweden, United Kingdom
-
Pharmiva ABKey2Compliance; Replior ABCompleted